[1] Misciagna G, Del PDM, Caramia DV, et al. Effect of a Low Glycemic Index Mediterranean Diet on Non-Alcoholic Fatty Liver Disease. A Randomized Controlled Clinici Trial. J Nutr Health Aging, 2017, 21: 404-412. [2] Botezelli JD, Cambri LT, Ghezzi AC, et al. Fructose-rich diet leads to reduced aerobic capacity and to liver injury in rats. Lipids Health Dis, 2012, 11: 78. [3] Kobayashi Y, Tatsumi H, Hattori M, et al. Comparisons of dietary intake in Japanese with non-alcoholic fatty liver disease and type 2 diabetes mellitus. J Clin Biochem Nutr, 2016, 59: 215-219. [4] Vos MB, Kimmons JE, Gillespie C, et al. Dietary fructose consumption among US children and adults: the Third National Health and Nutrition Examination Survey. Medscape J Med, 2008, 10: 160. [5] Aeberli I, Gerber PA, Hochuli M, et al. Low to moderate sugar-sweetened beverage consumption impairs glucose and lipid metabolism and promotes inflammation in healthy young men: a randomized controlled trial. Am J Clin Nutr, 2011, 94: 479-485. [6] Hamza RT, Ahmed AY, Rezk DG, et al. Dietary fructose intake in obese children and adolescents: relation to procollagen type III N-terminal peptide (P3NP) and non-alcoholic fatty liver disease. J Pediatr Endocrinol Metab, 2016, 29: 1345-1352. [7] Qin L, Zhang W, Yang Z, et al. Impaired lung function is associated with non-alcoholic fatty liver disease independently of metabolic syndrome features in middle-aged and elderly Chinese. BMC Endocr Disord, 2017, 17: 18. [8] 刘文华,齐越,贾冬. 非酒精性脂肪肝实验模型研究概况. 上海中医药杂志, 2015, 3: 95-97. [9] 刘静,柳银兰,杨文君,等. 高脂高果糖饮食诱导非酒精性脂肪性肝炎小鼠模型的建立和鉴定. 中华肝脏病杂志, 2014, 22: 445-450. [10] Jin CJ, Engstler AJ, Sellmann C, et al. Sodium butyrate protects mice from the development of the early signs of non-alcoholic fatty liver disease: role of melatonin and lipid peroxidation. Br J Nutr, 2016: 1-12. [11] Castro GS, Cardoso JF, Vannucchi H, et al. Fructose and NAFLD: metabolic implications and models of induction in rats. Acta Cir Bras, 2011, 26 Suppl 2: 45-50. [12] Bae JS, Park JM, Lee J, et al. Amelioration of non-alcoholic fatty liver disease with NPC1L1-targeted IgY or n-3 polyunsaturated fatty acids in mice. Metabolism, 2017, 66: 32-44. [13] 潘磊,张金彪,崔荣岗,等. 非酒精性脂肪肝C57BL/6小鼠模型的建立. 中国组织工程研究, 2016, 40: 6054-6059. |